Sanofi

Former head office 174 avenue de France, Paris 13th arrondissement Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in Forbes Global 2000 was 89.

Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Provided by Wikipedia
Showing 1 - 8 results of 8 for search 'Aventis', query time: 0.04s Refine Results
In addition to media from the THWS, media from other Bavarian libraries are also displayed.
These are marked with the "Interlibrary loan" label and can be ordered by clicking on them.
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    CSR Report Erfolg und nachhaltige Entwicklung

    Published 2012
    “…Sanofi-Aventis Deutschland GmbH (Frankfurt am Main)…”
    Get full text
  8. 8

    125 Jahre Arzneimittel aus Deutschland von Sanofi-Aventis

    Published 2008
    “…Sanofi-Aventis Deutschland GmbH (Frankfurt am Main)…”